NCT01286571View on ClinicalTrials.gov

Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

March 31, 2011

Conditions
Healthy
Interventions
DRUG

BI 135585

one oral single dose per subject

DRUG

BI 135585

one oral single dose per subject

Trial Locations (1)

Unknown

1283.3.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01286571 - Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food | Biotech Hunter | Biotech Hunter